Engineered Phage-Based Cancer Vaccines: Current Advances and Future Directions
Open Access
Abstract
Bacteriophages have emerged as versatile tools in the field of bioengineering, with enormous potential in tissue engineering, vaccine development, and immunotherapy. The genetic makeup of phages can be harnessed for the development of novel DNA vaccines and antigen display systems, as they can provide a highly organized and repetitive presentation of antigens to immune cells. Bacteriophages have opened new possibilities for the targeting of specific molecular determinants of cancer cells. Phages can be used as anticancer agents and carriers of imaging molecules and therapeutics. In this review, we explored the role of bacteriophages and bacteriophage engineering in targeted cancer therapy. The question of how the engineered bacteriophages can interact with the biological and immunological systems is emphasized to comprehend the underlying mechanism of phage use in cancer immunotherapy. The effectiveness of phage display technology in identifying high-affinity ligands for substrates, such as cancer cells and tumor-associated molecules, and the emerging field of phage engineering and its potential in the development of effective cancer treatments are discussed. We also highlight phage usage in clinical trials as well as the related patents. This review provides a new insight into engineered phage-based cancer vaccines.Keywords
Funding Information
- National Research Foundation of Korea (NRF) grant by the Korean Government (MSIT) (NRF-2020R1A2C2012316, 2021R1A2C2003908, 2021R1F1A1052110)
This publication has 249 references indexed in Scilit:
- Proteasome inhibition in cancer is associated with enhanced tumor targeting by the adeno‐associated virus/phageMolecular Oncology, 2012
- Bacteriophages and their genomesCurrent Opinion in Virology, 2011
- Crystal structure of the read‐through domain from bacteriophage Qβ A1 proteinProtein Science, 2011
- Evolutionary Selection of New Breast Cancer Cell-Targeting Peptides and Phages with the Cell-Targeting Peptides Fully Displayed on the Major Coat and Their Effects on Actin Dynamics during Cell InternalizationMolecular Pharmaceutics, 2010
- From combinatorial peptide selection to drug prototype (I): Targeting the vascular endothelial growth factor receptor pathwayProceedings of the National Academy of Sciences, 2010
- Structure of the Small Outer Capsid Protein, Soc: A Clamp for Stabilizing Capsids of T4-like PhagesJournal of Molecular Biology, 2010
- Viral vectors: from virology to transgene expressionBritish Journal of Pharmacology, 2009
- A preclinical model for predicting drug response in soft-tissue sarcoma with targeted AAVP molecular imagingProceedings of the National Academy of Sciences, 2008
- Assembly of the Small Outer Capsid Protein, Soc, on Bacteriophage T4: A Novel System for High Density Display of Multiple Large Anthrax Toxins and Foreign Proteins on Phage CapsidJournal of Molecular Biology, 2007
- In vivo gene delivery and expression by bacteriophage lambda vectorsJournal of Applied Microbiology, 2006